Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratory’s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution Genetics Investing
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel Genetics Investing
Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights Genetics Investing
HTG Molecular Diagnostics and Oncologie Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development Genetics Investing
QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics Genetics Investing